Long, Jw., Wang, Yy., Pi, Xm. et al. Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine., Chin. J. Integr. Med. 16, 353–356 (2010). https://doi.org/10.1007/s11655-010-0504-2
Jian-wen Long, Yu-ying Wang, Xian-ming Pi, et al. Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine[J]. Chinese Journal of Integrative Medicine, 2010,16(4):353-356.
Long, Jw., Wang, Yy., Pi, Xm. et al. Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine., Chin. J. Integr. Med. 16, 353–356 (2010). https://doi.org/10.1007/s11655-010-0504-2DOI:
Jian-wen Long, Yu-ying Wang, Xian-ming Pi, et al. Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine[J]. Chinese Journal of Integrative Medicine, 2010,16(4):353-356. DOI: 10.1007/s11655-010-0504-2.
Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine
摘要
To assess the effect and adverse reaction of total glucosides of paeony capsule (TGPC) in combining with citirizine for the treatment of chronic urticaria. A total of 120 patients were assigned to two groups by lottery
65 in the treated group and 55 in the control group. They all were orally treated with citirizine tablet 10 mg per day
but to the treated group
additional 0.2 g TGPC was given three times per day
the therapeutic course for both groups was 4 weeks. The effectiveness of treatment was observed
and the changes of total symptom score
serum levels of interleukin-4 (IL-4)
and immunoglobulin E (IgE) were measured before and after treatment. Moreover
a follow-up was carried out one month after ending the treatment. The dropped cases were two in the treated group and seven in the control group; so
the study was accomplished on 63 patients in the treated group and 48 patients in the control group. The total effective rate was assessed at 73.02% (46/63) in the treated group
which was significantly higher than 47.92% (23/48) in the control group (P<0.01). After treatment
the total symptom score decreased in both groups
but the decrement in the treated group was more significant (P<0.05). Serum levels of IL-4 and IgE in the treated group lowered significantly
while the changes in the control group were insignificant
so statistical significant differences were shown between groups (P<0.01). A follow-up study showed that the relapse rate in the treated group was 30.00% (6/20)
while that in the control group was 90.00% (9/10)
and the former was lower than the latter (P<0.01). Adverse reactions
revealed as drowsiness
dizziness
and weakness
were seen in eight cases and seven cases in the two groups
respectively. Besides
mild diarrhea occurred in two cases of the treated group. The treatment of TGPC combining citirizine shows definite curative effect in treating chronic urticaria
with low relapse rate and without evident adverse reaction. Its therapeutic effect might be realized by means of regulating patients’ immune function. Besides
the medication should be continued for a rather long period to achieve the full effect.
Abstract
To assess the effect and adverse reaction of total glucosides of paeony capsule (TGPC) in combining with citirizine for the treatment of chronic urticaria. A total of 120 patients were assigned to two groups by lottery
65 in the treated group and 55 in the control group. They all were orally treated with citirizine tablet 10 mg per day
but to the treated group
additional 0.2 g TGPC was given three times per day
the therapeutic course for both groups was 4 weeks. The effectiveness of treatment was observed
and the changes of total symptom score
serum levels of interleukin-4 (IL-4)
and immunoglobulin E (IgE) were measured before and after treatment. Moreover
a follow-up was carried out one month after ending the treatment. The dropped cases were two in the treated group and seven in the control group; so
the study was accomplished on 63 patients in the treated group and 48 patients in the control group. The total effective rate was assessed at 73.02% (46/63) in the treated group
which was significantly higher than 47.92% (23/48) in the control group (P<0.01). After treatment
the total symptom score decreased in both groups
but the decrement in the treated group was more significant (P<0.05). Serum levels of IL-4 and IgE in the treated group lowered significantly
while the changes in the control group were insignificant
so statistical significant differences were shown between groups (P<0.01). A follow-up study showed that the relapse rate in the treated group was 30.00% (6/20)
while that in the control group was 90.00% (9/10)
and the former was lower than the latter (P<0.01). Adverse reactions
revealed as drowsiness
dizziness
and weakness
were seen in eight cases and seven cases in the two groups
respectively. Besides
mild diarrhea occurred in two cases of the treated group. The treatment of TGPC combining citirizine shows definite curative effect in treating chronic urticaria
with low relapse rate and without evident adverse reaction. Its therapeutic effect might be realized by means of regulating patients’ immune function. Besides
the medication should be continued for a rather long period to achieve the full effect.
关键词
total glucosides of paeony capsulecitirizinecombined therapychronic urticaria observation
Keywords
total glucosides of paeony capsulecitirizinecombined therapychronic urticaria observation
The Clinical Cooperation Group, Yu BE, Liao KH. Therapeutic effect of mizolastine in the treatment of 6 970 patients with chronic urticaria. Chin J Dermatol (Chin) 2003;36:340–341.
Tang SS, Zheng XY, Sun GZ. Analysis of allergen specific IgE and specific IgG in patients with chronic urticaria. Exp Lab Med (Chin) 2009;27:121–122.
Yang YG. Detection of allergen and serum IgE antibodies in 192 cases of chronic urticaria. Modern Diag Treat (Chin) 2009;20:248.
Zheng WJ, Lin YK, Yan LL, Liang L. Clinical research on serum cytokines in patients with chronic urticaria. Chin J Clin Lab Sci (Chin) 2004;4:294.
Sun WL, Bi ZG. The level of serum IL-4 and IFN-γ in patients with autoimmune chronic urticaria. Acta Univ Med Nanjing (Chin) 2003;23:548–549.
Wang B, Chen MZ, Xu SY. Effect of total glucosides of paeony (TGP) on tumor necrosis factor produced by peritoneal macrophages in rats. Chin Pharmacol Bull 1995;11:38.
Wang B, Yao YY, Zhou AW. Study on immunomodulatory effect of total glucosides of paeony and its relationship with nitric oxide in adjuvant arthritis rats. Chin J Immunol (Chin) 1996;12:104.
Wang Y, Xing HY. Clinical observation on effect of total glucosides of paeony combined with methotrexate on rheumatoid arthritis. Chin J Integr Tradit West Med (Chin) 2007;27:839–840.
Wang SL, Wang JP, Bian H, Wang H, Li P. Clinical observation on total glucosides of paeony combined with sulfasalazine in treatment of ankylosing spondylitis. Chin J Integr Tradit West Med (Chin) 2007;27:217–219.